J B Chemicals & Pharmaceuticals Ltd

J B Chemicals & Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

J B Chemicals & Pharmaceuticals Ltd

₹ 1,755 4.34%
28 Jun - close price
jbpharma.com BSE: 506943 NSE: JBCHEPHARM
About

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally. [1]

Key Points

Revenue Split H1FY24
Domestic Formulations - 55%
Export Formulations - 30%
Contract Manufacturing - 13%
APIs - 2% [1]

Website BSE NSE
  • Market Cap ₹ 27,234 Cr.
  • Current Price ₹ 1,755
  • High / Low ₹ 1,940 / 1,132
  • Stock P/E 50.1
  • Book Value ₹ 186
  • Dividend Yield 0.51 %
  • ROCE 25.0 %
  • ROE 20.4 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 29.4%

Cons

  • Stock is trading at 9.43 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
490 546 527 533 584 716 740 729 699 853 837 800 809
364 388 412 419 462 548 574 559 538 618 602 585 614
Operating Profit 126 158 115 114 122 168 166 169 161 235 235 215 195
OPM % 26% 29% 22% 21% 21% 23% 22% 23% 23% 28% 28% 27% 24%
25 13 20 4 2 1 2 3 3 5 7 7 16
Interest 1 1 1 1 2 6 8 9 12 11 9 12 8
Depreciation 16 17 15 17 22 26 28 28 31 31 32 33 40
Profit before tax 134 153 118 101 100 137 132 136 122 198 201 176 163
Tax % 24% 25% 25% 26% 17% 26% 26% 26% 27% 27% 28% 27% 23%
103 115 88 75 83 101 98 101 89 145 145 128 126
EPS in Rs 6.63 7.46 5.72 4.82 5.35 6.55 6.32 6.54 5.73 9.34 9.36 8.25 8.11
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
816 957 1,061 1,144 1,175 1,250 1,501 1,641 1,892 2,190 2,884 3,299
705 802 868 917 952 1,050 1,209 1,270 1,340 1,681 2,219 2,419
Operating Profit 111 154 193 226 222 199 292 370 552 509 665 879
OPM % 14% 16% 18% 20% 19% 16% 19% 23% 29% 23% 23% 27%
26 -27 10 55 46 39 37 37 116 39 9 35
Interest 5 6 7 10 5 3 5 3 7 5 34 41
Depreciation 24 27 38 40 46 56 55 65 67 71 112 135
Profit before tax 108 94 159 231 217 179 269 340 594 471 527 738
Tax % 21% 27% 29% 22% 20% 29% 32% 21% 25% 23% 26% 26%
85 68 114 179 173 128 182 268 447 361 389 543
EPS in Rs 5.01 4.04 6.70 10.57 10.20 7.66 11.34 17.34 28.92 23.35 25.12 35.01
Dividend Payout % 30% 37% 105% 24% 5% 13% 22% 32% 29% 35% 35% 17%
Compounded Sales Growth
10 Years: 13%
5 Years: 17%
3 Years: 20%
TTM: 14%
Compounded Profit Growth
10 Years: 19%
5 Years: 26%
3 Years: 11%
TTM: 41%
Stock Price CAGR
10 Years: 36%
5 Years: 56%
3 Years: 28%
1 Year: 48%
Return on Equity
10 Years: 16%
5 Years: 19%
3 Years: 18%
Last Year: 20%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 17 17 17 17 17 17 16 15 15 15 15 16
Reserves 992 1,031 999 1,206 1,371 1,437 1,469 1,430 1,791 2,088 2,427 2,871
50 93 105 175 49 28 26 29 39 52 547 359
214 201 327 244 248 285 283 337 355 382 480 668
Total Liabilities 1,273 1,342 1,449 1,641 1,684 1,767 1,793 1,811 2,200 2,538 3,470 3,914
294 282 301 369 609 570 552 583 565 1,204 1,822 1,938
CWIP 5 46 55 135 4 17 15 16 26 19 55 63
Investments 434 536 598 612 544 567 589 536 811 146 339 531
540 477 495 525 528 613 636 676 799 1,170 1,254 1,381
Total Assets 1,273 1,342 1,449 1,641 1,684 1,767 1,793 1,811 2,200 2,538 3,470 3,914

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
80 -12 143 171 178 116 193 272 335 147 629 789
-112 -139 -122 -52 -42 -24 -28 24 -231 4 -956 -412
-31 12 -23 -97 -165 -59 -156 -305 -87 -138 343 -374
Net Cash Flow -62 -138 -2 22 -30 32 9 -10 18 13 16 3

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 87 95 85 85 82 88 73 77 72 86 66 69
Inventory Days 97 108 109 108 131 134 142 149 163 172 136 152
Days Payable 56 50 53 56 65 76 76 97 96 96 78 109
Cash Conversion Cycle 128 152 141 137 149 145 139 128 139 162 124 112
Working Capital Days 84 105 60 94 95 107 98 88 95 130 100 128
ROCE % 9% 13% 14% 17% 12% 9% 17% 22% 32% 22% 22%

Shareholding Pattern

Numbers in percentages

9 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
55.91% 55.91% 54.00% 54.00% 54.00% 53.96% 53.95% 53.93% 53.91% 53.86% 53.83% 53.78%
8.37% 8.74% 9.12% 9.22% 8.85% 8.66% 8.81% 8.62% 9.53% 10.05% 10.35% 11.06%
13.13% 15.23% 16.26% 16.89% 17.80% 18.47% 18.55% 19.08% 18.65% 18.58% 18.53% 18.38%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01%
22.58% 20.12% 20.62% 19.89% 19.35% 18.91% 18.72% 18.35% 17.90% 17.50% 17.27% 16.78%
No. of Shareholders 70,74071,78864,86161,31460,26858,62959,77956,63355,96560,81763,23063,892

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls